Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Fred Khosravi and AccessClosure (C)
Hamermesh, Richard G.; Barley, LaurenCaso HBS-814074-EIniciativa emprendedoraOn September 11, 2013, the three-judge panel of the U.S. Court of Appeals for the Federal Circuit denied St. Jude's request to rehear an appeal on the "double patenting" ruling for the '439 patent. Further, it removed the injunction threat that was hanging over the company. The future looked bright for AccessClosure as 2013 drew to a close. The company expected 2014 revenues of more than $100 million with a gross margin of greater than 70%. It wa...Desde 5,74 €
-
GenapSys: Business Models for the Genome
Hamermesh, Richard G.; Fuller, Joseph B.; Preble, MatthewCaso HBS-814050-EIniciativa emprendedoraGenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive-potentially costing just a few thousand dollars-and smaller than other sequencers, many of which were large devices costing tens of thousands or hundreds of thousands of dollars. GenapSys' device, named GENIUS, could also quickly genera...Desde 8,20 €
-
Intermountain Healthcare: Pursuing Precision Medicine, Teaching Note
Hamermesh, Richard G.; Huckman, Robert S.; Kelley, JuliaNota del Instructor HBS-820019-EIniciativa emprendedoraTeaching note for case 818018.Desde 0,00 €
-
Note on Implementing Strategy (Spanish version)
Hamermesh, Richard G.Caso HBS-314S10Dirección estratégicaPresents a framework for thinking about problems of implementing strategy. Defines the tasks of implementation and the range of implementation situations, then develops four approaches to implementation and reviews a range of implementation skills. Intended for use in Business Policy II in conjunction with case studies.Desde 8,20 €
-
Innovating Beyond Ochsner
Hamermesh, Richard G.; Hull, OliviaCaso HBS-817028-EIniciativa emprendedoraThe Ochsner Health System has developed a proprietary software tool designed to treat hypertension. Built into the system's electronic medical records, the Hypertension Digital Medicine program allows patients to record their blood pressure at home and share readings with their medical providers in real-time. A year and a half after launching the program, the health system's internal startup, innovationOchsner, has gathered promising clinical res...Desde 8,20 €
-
Meli Marine
Hamermesh, Richard G.; Yong, SunruCaso HBS-4426-EMeli Marine, a container shipping company, is facing an important strategic decision after an interesting acquisition opportunity presents itself. Founded in 1974 by the Chang Family, the Singapore-based company has carved out a niche in the intra-Asia transport market. After years of success, eroding business conditions caused a financial crisis and a new CEO, David Tian, was brought in. Tian created a successful strategic change effort that res...Desde 8,20 €
-
Snow Brand Milk Products (A): Assessing the Possibility for Revitalization
Werhane, Patricia H.; Mead, Jenny; Saito, Akira; Koehn, Daryl; Wolfe, ReginaCaso DARDEN-E-0347-EÉtica empresarial y Responsabilidad Social CorporativaThis three-case series, set in Japan, explores corporate responsibility and brand rebuilding in the face of a serious crisis. Suitable for MBA, executive education, and undergraduate students, it depicts a consumer advocate's decision-making process as she considers whether to help a company restore its badly tarnished reputation. In spring 2002, leading consumer activist Nobuko Hiwasa was invited to join the Japanese company Snow Brand Milk Prod...Desde 8,20 €
-
Realizing the Promise of Personalized Medicine
Aspinall, Mara G.; Hamermesh, Richard G.Artículo HBS-R0710F-EScientific advances have begun to give doctors the power to customize therapy for individuals. However, adoption of this approach has progressed slowly and unevenly because the trial-and-error treatment model still governs how the health care system develops, regulates, pays for, and delivers therapies. Aspinall, the president of Genzyme Genetics, and Hamermesh, chair of a Harvard Business School initiative to improve leadership in health care or...Desde 8,20 €